"Optimal" cost-effectiveness analyses?
Nightingale
S D
SD
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000191:economics*; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D006801:Humans; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000191:economics*